anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Sparkline

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 22,963
Current window 12,631-12,660
Pages 766
Rows per page 30
Arc: Sparklineclear collectionreset all
18 30 60

Arc

12,631-12,660 of 22,963

filter-aware
03
BenevolentAI | Investor Conference Presentation Deck | 29 slidesBenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Attention1 hit
04
BenevolentAI | Investor Conference Presentation Deck | 29 slidesBenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Attention1 hit
05
The central diagram represents a knowledge graph or network of interconnected biological data points.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Attention1 hit
06
The slide uses a process flow diagram to explain the platform's methodology.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
07
The slide features a screenshot of a software platform with a zoomed-in callout box showing a data table of mechanisms related to ALS.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
08
The slide shows a UI screenshot of a 'BenevolentAI' platform. It highlights a 'PPI Edge Details' modal window.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
09
The central diagram acts as a template for hypothesis generation: 'Can we treat [Target] by [Sign] [Mechanism] in [Cell type] by [Sign] [Mechanism]?'BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
10
The diagram shows a process flow from data inputs to model processing to target identification.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
11
The slide uses a combination of UI screenshots and a list of benefits to illustrate the platform's capabilities.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Desire1 hit
12
The slide highlights a 'Triage criteria' panel with sliders for Biological Rationale, Ligandability, Safety, Tissue Expression, and Therapeutic Evidence.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Desire1 hit
13
The slide shows a UI screenshot with a zoomed-in callout highlighting the 'Literature' tab and evidence table.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Desire1 hit
14
The slide uses a hub-and-spoke visual metaphor to connect various lab functions to the central facility.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Desire1 hit
15
BenevolentAI | Investor Conference Presentation Deck | 29 slidesBenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Desire1 hit
16
The chart uses a segmented bar approach to compare established industry players against BenevolentAI's projected output.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
17
The slide uses a hub-and-spoke style diagram to show how a central platform feeds into four different commercialization strategies.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
18
The chart uses a timeline-like structure to show drug development stages from Target ID to Phase II.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
19
The slide uses a two-column layout to contrast the disease burden (left) with the proposed therapeutic solution (right).BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
20
Includes specific caveats regarding study power and dosing duration.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
21
The slide uses a split-column layout to contrast the disease burden/market need (left) with the proposed solution/mechanism (right).BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
22
The slide uses a process diagram to show the experimental workflow (biopsy to culture to measurement) followed by bar charts showing cytokine reduction.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
23
The slide uses a combination of a horizontal timeline and a three-column process breakdown.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
24
The chart shows a horizontal bar representation of drug development stages. Some programs are marked with AstraZeneca partnership logos and dates.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
25
The slide uses a split-layout with a summary of the partnership on the left and a timeline of expansion on the right.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · ActionLoop · Before After1 hit
26
The slide is split into two main sections: a case study on baricitinib (left) and a partnership overview with DNDi (right).BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
27
BenevolentAI | Investor Conference Presentation Deck | 29 slidesBenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
28
BenevolentAI | Investor Conference Presentation Deck | 29 slidesBenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
29
Neon-style text effect on a dark blue background.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
BlackRock | Results Presentation Deck | 15 slidesBlackRock | Results Presentation Deck | 15 slides · BlackRock
Conference presentation Investor relations Beat · Current Situation1 hit
02
The slide uses stacked bar charts to compare AUM vs Base Fees for four different business segmentations.BlackRock | Results Presentation Deck | 15 slides · BlackRock
Conference presentation Investor relations Beat · Current SituationLoop · Cost Of Inaction1 hit
03
Includes legend for organic asset growth rate and organic base fee growth rate.BlackRock | Results Presentation Deck | 15 slides · BlackRock
Conference presentation Investor relations Beat · Current SituationLoop · Cost Of Inaction1 hit